文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

奥密克戎变异株及其对脆弱人群的威胁的最新情况。

Update on Omicron variant and its threat to vulnerable populations.

作者信息

Dai Bowen, Ji Wangquan, Zhu Peiyu, Han Shujie, Chen Yu, Jin Yuefei

机构信息

Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou, China.

Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, 450001, China.

出版信息

Public Health Pract (Oxf). 2024 Mar 25;7:100494. doi: 10.1016/j.puhip.2024.100494. eCollection 2024 Jun.


DOI:10.1016/j.puhip.2024.100494
PMID:38584806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10998192/
Abstract

OBJECTIVE: To reduce the incidence of severe illness and fatalities, and promote the awareness of protection and precaution, increased vaccination, strengthen the physical fitness, frequent ventilation, and health education should be enhanced among vulnerable populations as essential measures for the future control of COVID-19. STUDY DESIGN: Systematic review. METHOD: The search was done using PubMed, EMBASE and Web of Science for studies without language restrictions, published up through March 2023, since their authoritative and comprehensive literature search database. Eighty articles were included. Extraction of articles and quality assessment of included reviews was performed independently by two authors using the AMSTAR 2 score. RESULTS: The articles in the final data set included research on epidemiological characteristics, pathogenicity, available vaccines, treatments and epidemiological features in special populations including the elders, pregnant women, kids, people with chronic diseases concerning Omicron. CONCLUSION: Although less pathogenic potential is found in Omicron, highly mutated forms have enhanced the ability of immune evasion and resistance to existing vaccines compared with former variants. Severe complications and outcomes may occur in vulnerable populations. Infected pregnant women are more likely to give birth prematurely, and fatal implications in children infected with Omicron are hyperimmune response and severe neurological disorders. In immunocompromised patients, there is a greater reported mortality and complication compared to patients with normal immune systems. Therefore, maintain social distancing, wear masks, and receive vaccinations are effective long-term measures.

摘要

目的:为降低重症和死亡发生率,提高防护和预防意识,增加疫苗接种,增强体质,加强通风,并对脆弱人群加强健康教育,这些是未来控制新冠疫情的关键措施。 研究设计:系统评价。 方法:通过检索PubMed、EMBASE和Web of Science,查找截至2023年3月发表的无语言限制的研究,因其文献检索数据库具有权威性和全面性。共纳入80篇文章。由两位作者使用AMSTAR 2评分独立进行文章提取和对纳入综述的质量评估。 结果:最终数据集中的文章包括关于奥密克戎毒株的流行病学特征、致病性、可用疫苗、治疗方法以及包括老年人、孕妇、儿童、慢性病患者等特殊人群的流行病学特征的研究。 结论:尽管奥密克戎毒株的致病潜力较低,但与先前变体相比,高度变异的形式增强了免疫逃逸能力和对现有疫苗的抗性。脆弱人群可能会出现严重并发症和不良后果。感染的孕妇更易早产,感染奥密克戎毒株的儿童出现的致命影响是超免疫反应和严重神经障碍。与免疫系统正常的患者相比,免疫功能低下患者的死亡率和并发症报告更多。因此,保持社交距离、佩戴口罩和接种疫苗是有效的长期措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a69/10998192/0577c9fc736e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a69/10998192/78bb92182d8c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a69/10998192/0577c9fc736e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a69/10998192/78bb92182d8c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a69/10998192/0577c9fc736e/gr2.jpg

相似文献

[1]
Update on Omicron variant and its threat to vulnerable populations.

Public Health Pract (Oxf). 2024-3-25

[2]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[3]
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.

Elife. 2022-8-25

[4]
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.

Med J Aust. 2020-12

[5]
Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review.

Cochrane Database Syst Rev. 2022-8-9

[6]
Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022-3-28

[7]
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.

BMC Infect Dis. 2023-6-26

[8]
Omicron variant of SARS-CoV-2 infection elicits cross-protective immunity in people who received boosters or infected with variant strains.

Int J Immunopathol Pharmacol. 2022

[9]
Real-world evidence on the efficacy of bivalent booster doses of SARS-CoV-2 vaccine in respect of monovalent boosters or primary cycle of vaccination: a narrative review.

Epidemiol Prev. 2023

[10]
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19.

Heliyon. 2024-2-19

引用本文的文献

[1]
Comparison of SARS-CoV-2 IgG responses in hemodialysis patients and healthcare workers after COVID-19 vaccination.

Front Immunol. 2025-7-15

[2]
Characterization of the Binding and Inhibition Mechanisms of a Novel Neutralizing Monoclonal Antibody Targeting the Stem Helix Region in the S2 Subunit of the Spike Protein of SARS-CoV-2.

Vaccines (Basel). 2025-6-26

[3]
Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant.

Sci Rep. 2025-5-15

[4]
Public perception of COVID-19 in Saudi Arabia during the Omicron wave: recommendations for policy improvement.

Front Public Health. 2025-2-27

[5]
SARS-CoV-2 Variants and Clinical Outcomes of Special Populations: A Scoping Review of the Literature.

Viruses. 2024-7-30

本文引用的文献

[1]
Risk factors for the in‑hospital and 1‑year mortality of elderly patients hospitalized due to COVID‑19‑related pneumonia.

Exp Ther Med. 2023-11-20

[2]
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.

Lancet Reg Health Eur. 2023-10-13

[3]
Differences in the severity and mortality risk factors for patients hospitalized for COVID-19 pneumonia between the early wave and the very late stage of the pandemic.

Front Med (Lausanne). 2023-9-28

[4]
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.

Nat Commun. 2023-4-17

[5]
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.

Lancet Rheumatol. 2023-2

[6]
Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system.

Clin Microbiol Infect. 2023-6

[7]
Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study.

PLoS Med. 2023-1

[8]
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.

Cell. 2023-1-19

[9]
Antibiotics Usage and Resistance among Patients with Severe Acute Respiratory Syndrome Coronavirus 2 in the Intensive Care Unit in Makkah, Saudi Arabia.

Vaccines (Basel). 2022-12-14

[10]
Preclinical Toxicity and Immunogenicity of a COVID-19 Vaccine (ZF2001) in Cynomolgus Monkeys.

Vaccines (Basel). 2022-12-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索